Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1933 2
1938 1
1948 1
1950 2
1952 1
1953 1
1954 1
1964 3
1965 3
1967 5
1968 2
1969 3
1970 5
1971 4
1972 3
1973 6
1974 8
1975 6
1976 6
1977 3
1978 11
1979 8
1980 6
1981 9
1982 10
1983 10
1984 12
1985 20
1986 13
1987 11
1988 14
1989 12
1990 9
1991 23
1992 18
1993 20
1994 38
1995 42
1996 37
1997 30
1998 31
1999 37
2000 53
2001 50
2002 45
2003 63
2004 59
2005 89
2006 125
2007 133
2008 173
2009 168
2010 174
2011 207
2012 286
2013 240
2014 287
2015 284
2016 312
2017 352
2018 343
2019 382
2020 498
2021 603
2022 561
2023 555
2024 568
2025 416
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,542 results

Results by year

Filters applied: . Clear all
Page 1
Atherosclerosis Is a Smooth Muscle Cell-Driven Tumor-Like Disease.
Pan H, Ho SE, Xue C, Cui J, Johanson QS, Sachs N, Ross LS, Li F, Solomon RA, Connolly ES Jr, Patel VI, Maegdefessel L, Zhang H, Reilly MP. Pan H, et al. Among authors: patel vi. Circulation. 2024 Jun 11;149(24):1885-1898. doi: 10.1161/CIRCULATIONAHA.123.067587. Epub 2024 Apr 30. Circulation. 2024. PMID: 38686559 Free PMC article.
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators. Motzer R, et al. Among authors: patel v. N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. N Engl J Med. 2021. PMID: 33616314 Clinical Trial.
The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain.
Aman MM, Mahmoud A, Deer T, Sayed D, Hagedorn JM, Brogan SE, Singh V, Gulati A, Strand N, Weisbein J, Goree JH, Xing F, Valimahomed A, Pak DJ, El Helou A, Ghosh P, Shah K, Patel V, Escobar A, Schmidt K, Shah J, Varshney V, Rosenberg W, Narang S. Aman MM, et al. Among authors: patel v. J Pain Res. 2021 Jul 16;14:2139-2164. doi: 10.2147/JPR.S315585. eCollection 2021. J Pain Res. 2021. PMID: 34295184 Free PMC article. Review.
Favre-Racouchot Syndrome.
Gaurav V, Patel V. Gaurav V, et al. Among authors: patel v. J Cutan Med Surg. 2024 Nov-Dec;28(6):619. doi: 10.1177/12034754241274324. Epub 2024 Sep 3. J Cutan Med Surg. 2024. PMID: 39225296 No abstract available.
Corona Seborrhica.
Gaurav V, Patel V. Gaurav V, et al. Among authors: patel v. J Cutan Med Surg. 2024 Nov-Dec;28(6):617. doi: 10.1177/12034754241274319. Epub 2024 Aug 30. J Cutan Med Surg. 2024. PMID: 39215470 No abstract available.
Aquagenic Keratoderma.
Patel V, Mehta N. Patel V, et al. J Cutan Med Surg. 2024 Nov-Dec;28(6):616. doi: 10.1177/12034754241269989. Epub 2024 Aug 5. J Cutan Med Surg. 2024. PMID: 39104152 No abstract available.
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.
Rischin D, Porceddu S, Day F, Brungs DP, Christie H, Jackson JE, Stein BN, Su YB, Ladwa R, Adams G, Bowyer SE, Otty Z, Yamazaki N, Bossi P, Challapalli A, Hauschild A, Lim AM, Patel VA, Walker JL, De Liz Vassen Schurmann M, Queirolo P, Cañueto J, Ferreira da Silva FA, Stratigos A, Guminski A, Lin C, Damian F, Flatz L, Taylor AE, Carr DR, Harris S, Kirtbaya D, Quereux G, Rutkowski P, Basset-Seguin N, Khushalani NI, Robert C, Ju H, Joseph C, Bansal S, Chen CI, Seebach F, Yoo SY, Lowy I, Goncalves P, Fury MG; C-POST Trial Investigators. Rischin D, et al. Among authors: patel va. N Engl J Med. 2025 Aug 21;393(8):774-785. doi: 10.1056/NEJMoa2502449. Epub 2025 May 31. N Engl J Med. 2025. PMID: 40454639 Clinical Trial.
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321).
Sharman JP, Munir T, Grosicki S, Roeker LE, Burke JM, Chen CI, Grzasko N, Follows G, Mátrai Z, Sanna A, Qiu L, Feng R, Hua VM, Jurczak W, Ritgen M, Yi S, Bosch F, Coombs CC, Bao K, Patel V, Liu B, Compte L, Guntur A, Wang DY, Hill M, Leow CC, Ghia P, Barr PM. Sharman JP, et al. Among authors: patel v. J Clin Oncol. 2025 Aug;43(22):2538-2549. doi: 10.1200/JCO-25-00166. Epub 2025 Jun 6. J Clin Oncol. 2025. PMID: 40479620 Free PMC article. Clinical Trial.
Dopamine D1-D2 signalling in hippocampus arbitrates approach and avoidance.
Godino A, Salery M, Minier-Toribio AM, Patel V, Fullard JF, Kondev V, Parise EM, Martinez-Rivera FJ, Morel C, Roussos P, Blitzer RD, Nestler EJ. Godino A, et al. Among authors: patel v. Nature. 2025 Jul;643(8071):448-457. doi: 10.1038/s41586-025-08957-5. Epub 2025 May 7. Nature. 2025. PMID: 40335693
6,542 results